FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Authors
Keywords
-
Journal
eLife
Volume 8, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2019-09-03
DOI
10.7554/elife.47327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling
- (2019) Zhongyi Fan et al. CANCER LETTERS
- FAK and β‐Catenin Cooperate to Induce Hepatocellular Carcinoma
- (2019) Shang Na et al. HEPATOLOGY
- Rgnef promotes ovarian tumor progression and confers protection from oxidative stress
- (2019) Elizabeth G. Kleinschmidt et al. ONCOGENE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- (2018) Tathiane M. Malta et al. CELL
- The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis
- (2018) Marjaana Ojalill et al. PROSTATE
- Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer
- (2018) Hui-Ming Lin et al. PROSTATE
- Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
- (2018) Ulrich A. Hirt et al. Oncogenesis
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
- (2018) Charles Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer
- (2017) Guangming Chen et al. MOLECULAR CANCER THERAPEUTICS
- IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
- (2017) Bryan Serrels et al. Science Signaling
- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
- (2017) Oliver M.T. Pearce et al. Cancer Discovery
- The regulation of β-catenin activity and function in cancer: therapeutic opportunities
- (2017) Shuang Shang et al. Oncotarget
- Inhibition of FAK kinase activity preferentially targets cancer stem cells
- (2017) Vihren N. Kolev et al. Oncotarget
- IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
- (2017) Bryan Serrels et al. Science Signaling
- The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
- (2017) Alpana Kumari et al. Genes
- Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
- (2017) B Xu et al. Oncogenesis
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2016) J. C. Soria et al. ANNALS OF ONCOLOGY
- A systematic comparison of copy number alterations in four types of female cancer
- (2016) Fatemeh Kaveh et al. BMC CANCER
- Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
- (2016) Curtis A. Clark et al. CANCER RESEARCH
- CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma
- (2016) J. Walton et al. CANCER RESEARCH
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
- (2016) Monika Haemmerle et al. JOURNAL OF CLINICAL INVESTIGATION
- Can advanced-stage ovarian cancer be cured?
- (2016) Steven Narod Nature Reviews Clinical Oncology
- Cisplatin induces stemness in ovarian cancer
- (2016) Andrew Wiechert et al. Oncotarget
- CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
- (2016) Eric Talevich et al. PLoS Computational Biology
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78
- (2015) L. Mo et al. MOLECULAR CANCER THERAPEUTICS
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β
- (2015) Chenxi Gao et al. eLife
- MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
- (2014) Zsófia Pénzváltó et al. BMC CANCER
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- FAK Inhibition Disrupts a 5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
- (2014) I. Tancioni et al. MOLECULAR CANCER THERAPEUTICS
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- Ovarian cancer stem cells: Are they real and why are they important?
- (2013) Monjri M. Shah et al. GYNECOLOGIC ONCOLOGY
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
- (2013) Daehwan Kim et al. GENOME BIOLOGY
- Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
- (2012) Kristy K. Ward et al. CLINICAL & EXPERIMENTAL METASTASIS
- VEGF-Induced Vascular Permeability Is Mediated by FAK
- (2012) Xiao Lei Chen et al. DEVELOPMENTAL CELL
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling
- (2012) H. Sakane et al. JOURNAL OF CELL SCIENCE
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells
- (2011) Alan Serrels et al. INTERNATIONAL JOURNAL OF CANCER
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
- (2011) Aphrothiti J. Hanrahan et al. Cancer Discovery
- PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments
- (2010) Isabelle Tanjoni et al. CANCER BIOLOGY & THERAPY
- Focal Adhesion Kinase Is Required for Intestinal Regeneration and Tumorigenesis Downstream of Wnt/c-Myc Signaling
- (2010) Gabrielle H. Ashton et al. DEVELOPMENTAL CELL
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Knock-in Mutation Reveals an Essential Role for Focal Adhesion Kinase Activity in Blood Vessel Morphogenesis and Cell Motility-Polarity but Not Cell Proliferation
- (2010) Ssang-Taek Lim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
- (2010) Ellen L Goode et al. NATURE GENETICS
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
- (2010) Kylie L. Gorringe et al. PLoS One
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started